Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$905000.0.

  • PAVmed's Net Cash Flow changed N/A to -$905000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of -$18.5 million for FY2024, which is 798.31% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's Net Cash Flow is -$905000.0.
  • PAVmed's 5-year Net Cash Flow high stood at $9.5 million for Q1 2023, and its period low was -$17.0 million during Q4 2022.
  • Moreover, its 4-year median value for Net Cash Flow was -$471000.0 (2024), whereas its average is -$3.5 million.
  • Per our database at Business Quant, PAVmed's Net Cash Flow tumbled by 301274.04% in 2023 and then skyrocketed by 356486.49% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Net Cash Flow stood at -$17.0 million in 2022, then surged by 60.28% to -$6.8 million in 2023, then soared by 105.53% to $374000.0 in 2024, then plummeted by 341.98% to -$905000.0 in 2025.
  • Its Net Cash Flow stands at -$905000.0 for Q3 2025, versus $1.3 million for Q2 2025 and $1.5 million for Q1 2025.